# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Along with a growing scientific corpus supporting the therapeutic potential of psychedelics, several states and most noticeably...
Experts gathered at the Benzinga Psychedelics Capital Conference in Miami Beach on Thursday where they talked about revolutioni...
Psychedelic Therapy Now Available As Workplace Benefit, Free Month For Laid-Off Tech Workers
Psychedelic therapeutics biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed three additional U.S.
Biotech company PsyBio Therapeutics Corp. (OTCQB: PSYBF) has filed four new U.S. Patent Cooperation Treaty (PCT) applications a...
Psychedelic Research & Fed Funding By The National Institute Of Mental Health The National Institute of Mental Health (NIM...
PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) reported its unaudited interim financial results for the three and nine-m...
The current clinical scenario sets psilocybin as one of the most advanced psychedelics, expected to become legally approved in ...
The Chart represents the liquidity positions of the 21 Psychedelic sector companies in the Viridian Value Tracker database.